Ascendis Pharma A/S organizacji EBIT margin
Jaka jest wartość EBIT margin organizacji Ascendis Pharma A/S?
Wartość EBIT margin organizacji Ascendis Pharma A/S to -2,523.61%
Jaka jest definicja EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin firm w Health Care sektor na NASDAQ w porównaniu do Ascendis Pharma A/S
Czym się zajmuję organizacja Ascendis Pharma A/S?
ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.
Firmy z ebit margin podobne do Ascendis Pharma A/S
- Wartość EBIT margin organizacji Chiasma Inc to -2,677.79%
- Wartość EBIT margin organizacji Altimmune to -2,649.99%
- Wartość EBIT margin organizacji Arrowhead Pharmaceuticals to -2,631.09%
- Wartość EBIT margin organizacji AnaptysBio to -2,608.86%
- Wartość EBIT margin organizacji Electreon Wireless Ltd to -2,570.39%
- Wartość EBIT margin organizacji MicroVision to -2,551.99%
- Wartość EBIT margin organizacji Ascendis Pharma A/S to -2,523.61%
- Wartość EBIT margin organizacji Immunome to -2,435.02%
- Wartość EBIT margin organizacji Phathom Pharmaceuticals Inc to -2,410.19%
- Wartość EBIT margin organizacji Lumos Pharma Inc to -2,405.72%
- Wartość EBIT margin organizacji Stagezero Life Sciences Ltd to -2,403.46%
- Wartość EBIT margin organizacji Esstra Industries to -2,381.88%
- Wartość EBIT margin organizacji Avidity Biosciences to -2,381.82%